Why is Bliss GVS Pharma falling/rising?

As of 26-Jun, Bliss GVS Pharma Ltd is currently priced at 149.00, reflecting a decrease of 0.35, or 0.23%. The stock has underperformed its sector by 0.31% today, despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a strong performance with a return of 9.84%, and a notable 19.10% increase over the past month. However, it has faced challenges with a significant drop in delivery volume, which fell by 50.15% compared to the 5-day average. While the stock has generated a substantial return of 44.94% over the past year, it is important to note that the company's profits have declined by 19.5%, indicating potential concerns regarding its profitability despite a low debt-to-equity ratio and attractive valuation.
In the broader market context, Bliss GVS Pharma's recent performance has outpaced the benchmark Sensex, which has only increased by 2.94% over the past week and 1.92% over the past month. However, the stock's year-to-date performance shows a decline of 9.51%, contrasting with the Sensex's gain of 7.19%. This divergence suggests that while the stock has performed well in the short term, its long-term trajectory remains uncertain, particularly given the falling profits and reduced investor participation. Overall, the stock's recent price movement reflects a complex interplay of strong short-term returns against a backdrop of declining profitability and reduced trading activity.